AstraZeneca expands its global hub in Bangalore, creating 400 new jobs and enhancing its presence in India.
The expansion, costing Rs 166 crore, will focus on AI-powered innovation in research and development, global business services, IT, and digital health operations.
The new facility will support AstraZeneca's ambition to deliver 20 new medicines by 2030 and strengthen its R&D capabilities through connections with India's scientific and technological expertise.
The Bangalore hub aligns with the goal of creating high-value employment opportunities, fostering innovation, and making Bangalore a global biotechnology and R&D hub.